These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7636875)

  • 1. Synthesis and dopaminergic activity of pyridine analogs of 5-hydroxy-2-(di-n-propylamino)tetralin.
    Glase SA; Corbin AE; Pugsley TA; Heffner TG; Wise LD
    J Med Chem; 1995 Aug; 38(16):3132-7. PubMed ID: 7636875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo evaluation of the binding of the dopamine D2 receptor agonist (11)C-(R,S)-5-hydroxy-2-(di-n-propylamino)tetralin in rodents and nonhuman primate.
    Mukherjee J; Narayanan TK; Christian BT; Shi B; Dunigan KA; Mantil J
    Synapse; 2000 Jul; 37(1):64-70. PubMed ID: 10842352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F; Newman-Tancredi A; Audinot V; Millan MJ
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
    Yu H; Liu Y; Malmberg A; Mohell N; Hacksell U; Lewander T
    Eur J Pharmacol; 1996 May; 303(3):151-62. PubMed ID: 8813561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of dopamine autoreceptors in the hypoactivity induced by 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.
    Chojnacka-Wójcik E
    Pol J Pharmacol Pharm; 1992; 44(2):135-46. PubMed ID: 1357637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (R)- and (S)-5-hydroxy-2-(dipropylamino)tetralin (5-OH DPAT): assessment of optical purities and dopaminergic activities.
    Karlsson A; Björk L; Pettersson C; Andén NE; Hacksell U
    Chirality; 1990; 2(2):90-5. PubMed ID: 1976017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3H]7-OH-DPAT is capable of labeling dopamine D2 as well as D3 receptors.
    Gonzalez AM; Sibley DR
    Eur J Pharmacol; 1995 Jan; 272(1):R1-3. PubMed ID: 7713138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine D3-preferring ligands act at synthesis modulating autoreceptors.
    Aretha CW; Sinha A; Galloway MP
    J Pharmacol Exp Ther; 1995 Aug; 274(2):609-13. PubMed ID: 7636720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine interactions measured by microdialysis in the ventral tegmental area of rats treated systemically with (+/-)-8-hydroxy-2-(di-n-propylamino)tetralin.
    Chen NH; Reith ME
    J Neurochem; 1995 Apr; 64(4):1585-97. PubMed ID: 7891086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A dose-response study of separate and combined effects of the serotonin agonist 8-OH-DPAT and the dopamine agonist quinpirole on locomotor sensitization, cross-sensitization, and conditioned activity.
    Johnson EF; Szechtman H
    Behav Pharmacol; 2016 Aug; 27(5):439-50. PubMed ID: 26871406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D2-like receptors mediate the expulsion phase of ejaculation elicited by 8-hydroxy-2-(di-N-propylamino)tetralin in rats.
    Clément P; Bernabé J; Kia HK; Alexandre L; Giuliano F
    J Pharmacol Exp Ther; 2006 Feb; 316(2):830-4. PubMed ID: 16221741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
    Protais P; Lesourd M; Comoy E
    Eur J Pharmacol; 1998 Jul; 352(2-3):179-87. PubMed ID: 9716353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodents.
    Protais P; Chagraoui A; Arbaoui J; Mocaër E
    Eur J Pharmacol; 1994 Dec; 271(1):167-77. PubMed ID: 7698199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The acute and chronic administration of (+/-)-8-hydroxy-2-(Di-n-propylamino)tetralin significantly alters the activity of spontaneously active midbrain dopamine neurons in rats: an in vivo electrophysiological study.
    Nakamura K; Suzuki K; McCreary AC; Ashby CR
    Synapse; 2006 May; 59(6):359-67. PubMed ID: 16463399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses.
    Trillat AC; Malagié I; Mathé-Allainmat M; Anmela MC; Jacquot C; Langlois M; Gardier AM
    Eur J Pharmacol; 1998 Apr; 347(1):41-9. PubMed ID: 9650846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the human dopamine D3 receptor expressed in transfected cell lines.
    MacKenzie RG; VanLeeuwen D; Pugsley TA; Shih YH; Demattos S; Tang L; Todd RD; O'Malley KL
    Eur J Pharmacol; 1994 Jan; 266(1):79-85. PubMed ID: 7907989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C1- and C3-methyl-substituted derivatives of 7-hydroxy-2-(di-n-propylamino)tetralin: activities at central dopamine receptors.
    Johansson AM; Nilsson JL; Karlén A; Hacksell U; Sanchez D; Svensson K; Hjorth S; Carlsson A; Sundell S; Kenne L
    J Med Chem; 1987 Oct; 30(10):1827-37. PubMed ID: 3656358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive hypothermic effects of the 5-HT1A receptor agonist 8-OH-DPAT and the dopamine D2/3 receptor agonist 7-OH-DPAT in the rat.
    Eltayb A; Lindblom S; Oerther S; Ahlenius S
    Acta Physiol Scand; 2001 Jul; 172(3):205-9. PubMed ID: 11472307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Centrally acting serotonergic agents. Synthesis and structure-activity relationships of C-1- or C-3-substituted derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin.
    Lin CH; Haadsma-Svensson SR; Lahti RA; McCall RB; Piercey MF; Schreur PJ; VonVoigtlander PF; Chidester CG
    J Med Chem; 1993 Mar; 36(6):671-82. PubMed ID: 8459396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo evidence for preferential role of dopamine D3 receptor in the presynaptic regulation of dopamine release but not synthesis.
    Gainetdinov RR; Sotnikova TD; Grekhova TV; Rayevsky KS
    Eur J Pharmacol; 1996 Jul; 308(3):261-9. PubMed ID: 8858296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.